Karyopharm Therapeutics Inc. (KPTI): Cash & Equivalents
$60.54M
As of 2025-12-31
$54.98M
As of 2026-06-30
-23.5%
3-year compound annual growth
-6.8%
5-year compound annual growth
+0.4%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $60.54M | -3.1% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $62.48M | +19.6% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $52.23M | -61.4% | 2026-02-13, Balance as of period end |
| 2022-12-31 | $135.19M | -29.0% | 2025-02-19, Balance as of period end |
| 2021-12-31 | $190.46M | +121.7% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $85.92M | -33.3% | 2023-02-17, Balance as of period end |
| 2019-12-31 | $128.86M | +9.2% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $118.02M | +71.1% | 2021-02-24, Balance as of period end |
| 2017-12-31 | $69.00M | +38.9% | 2020-02-26, Balance as of period end |
| 2016-12-31 | $49.66M | -14.9% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $58.36M | -61.3% | 2018-03-15, Balance as of period end |
| 2014-12-31 | $150.61M | -3.4% | 2017-03-16, Balance as of period end |
| 2013-12-31 | $155.97M | n/m | 2016-03-15, Balance as of period end |
| 2012-12-31 | $391.0K | -94.0% | 2015-03-13, Balance as of period end |
| 2011-12-31 | $6.51M | n/a | 2014-03-21, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $60.54M | -3.1% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $57.22M | -68.7% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $28.65M | +11.0% |
| Liquidia Corp (LQDA) | 2025-12-31 | $190.68M | +8.0% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.27M | -2.3% |
| Xencor Inc (XNCR) | 2025-12-31 | $54.07M | +32.3% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $134.93M | -12.4% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $129.97M | -56.3% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $250.49M | +633.8% |
Compare KPTI, MGNX, HRTX, LQDA side by side · Screen every company in Pharmaceutical Preparations ↗